Manufacturing High-Potency LGG: Stability and CFU Retention
Learn why high-potency LGG products lose viable cells and how manufacturers protect CFU retention through moisture control, packaging, and stability testing.
Manufacturing High-Potency LGG Products: Stability and CFU Retention Challenges
Lactobacillus rhamnosus GG (LGG) is one of the most widely studied probiotic strains, and CFU, or colony forming units, is the number that tells you how many live, active bacteria a product contains. Keeping that number intact is the real manufacturing challenge. LGG does not form spores, so every stage from drying to filling to storage can quietly cost you viable cells.
Quick Answer
High-potency LGG loses live cells mainly to moisture, heat, oxygen, and processing stress. Manufacturers protect the count by keeping water activity low, choosing moisture-friendly excipients, using barrier packaging, and testing stability right up to expiry.
Why Is LGG Harder to Stabilize Than Bacillus Probiotics?
Bacillus strains can turn into spores, a dormant form that shrugs off heat and dryness. LGG cannot. Its cells stay fully exposed from the moment they are dried until the day the consumer takes the dose.
That exposure matters more as potency climbs. A capsule such as Rhambac® GG, which delivers 6 billion CFU per dose, leaves very little room for avoidable loss. If the count slips below the label claim before expiry, the product has failed its promise, even if it looked fine at release.
What Causes LGG to Lose Viability?
Moisture and water activity
Moisture does the most damage. Water activity is a measure of how much unbound water in a powder is free for microbes to use. Once it rises, dormant LGG cells become active, burn through their energy reserves, and die off. A perfectly sealed pack cannot rescue a powder that was damp at the time of filling.
Heat and oxygen
Warmth speeds up cell death, and oxygen attacks the cell membrane. Both are a genuine concern in India's hot, humid conditions, which is why regional stability studies commonly run at 30°C and 75% relative humidity.
Processing stress
Freeze-drying, milling, blending, and compression all put physical strain on the cells. Tablet compression is particularly rough on LGG. That is a big reason capsules and sachets tend to be the formats of choice for high-count products.
How Do Manufacturers Protect CFU Counts?
Begin with a well-protected culture
Freeze-dried LGG is normally prepared with protectants such as trehalose or skim milk solids, which cushion the cell membrane during drying and slow the decline in storage. Supplier quality is part of this too. A reliable source documents strain identity and starting viable count for each batch.
Pick excipients with moisture in mind
Some fillers pull water from the air and hand it straight to the bacteria. Low-moisture, inert carriers are usually the safer bet. In capsules, HPMC shells generally hold less water than gelatin, which can help a sensitive blend.
Keep the production environment dry
Blending and filling belong in low-humidity rooms. Just as important, the powder should spend as little time as possible exposed between steps.
Match the packaging to the product
Alu-alu blisters, desiccant-lined bottles, and nitrogen-flushed foil sachets all restrict moisture and oxygen. Which one fits best depends on the dosage form, the dose, and the climate the product will face on shelves.
What Is Overage, and Is It a Good Idea?
Overage means filling a little more live culture than the label states, so the count still holds at expiry. It is a common and accepted practice, but only when it rests on real stability data. It cannot replace good process control, and a very large overage often hints at a deeper stability problem.
How Is Stability Confirmed?
Real-time and accelerated stability studies measure CFU at fixed intervals across the shelf life. Plate counts vary naturally from run to run, so the method should be validated and the results read as a trend, not as a single number. A batch that passes at release but fails at expiry has not really passed.
Key Takeaways
- LGG does not form spores, so it is sensitive to moisture, heat, and oxygen.
- Low water activity is the most important single control point.
- Excipients, capsule shells, and packaging all affect how many cells survive.
- Overage should be backed by stability data, not used as a shortcut.
- Testing under climate-relevant conditions shows whether the label claim holds at expiry.
Final Thoughts
For brand owners sourcing private label LGG, the best questions are practical ones. Ask to see stability reports, packaging specifications, and the enumeration method behind each CFU claim. A GMP Certified and US FDA Registered manufacturer should be comfortable sharing these, and the answers will tell you more than the figure printed on the pack.
Frequently Asked Questions
Explore More Articles
QualityTriple & Multi-Strain Probiotic Formulations: Manufacturing Complex Blends
Learn how manufacturers formulate triple and multi-strain probiotics while managing strain compatibility, potency, stability, processing, testing, and packaging.
GMP Certified & US FDA Registered Manufacturing Checklist
GMP Certified and US FDA Registered mean different things. Here is what each covers and what to check before you hand your probiotic brand to a manufacturer.
Manufacturing Considerations for Spore-Based Probiotic Vials and Syrups
Manufacturing spore-based probiotic vials and syrups requires careful control of strain identity, spore count, formulation compatibility, dose uniformity and shelf-life stability. From continuous mixing and preservative testing to GMP manufacturing and expiry-date CFU verification, each step helps ensure a consistent and reliable probiotic product.
Stay in the Loop
Get the latest probiotic industry insights delivered to your inbox.
